SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-028376
Filing Date
2024-02-08
Accepted
2024-02-08 16:23:39
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d724643d424b5.htm 424B5 470991
2 EX-FILING FEES d724643dexfilingfees.htm EX-FILING FEES 19463
3 GRAPHIC g724643g01o01.jpg GRAPHIC 37512
4 GRAPHIC g724643g03g03.jpg GRAPHIC 129998
5 GRAPHIC g724643g08y42.jpg GRAPHIC 34726
6 GRAPHIC g724647g00w78.jpg GRAPHIC 591674
  Complete submission text file 0001193125-24-028376.txt   1570333
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276872 | Film No.: 24609430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)